|
|
|
51-200 employees
View all
|
|
pharmaceuticals
|
|
7000 Shoreline Court,South San Francisco,CA,US
|
|
Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density.Tricida was founded in August 2013 by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with substantial expertise in developing polymers for the treatment of kidney-related diseases.
|
Tricida, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Tricida, Inc. email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Tricida, Inc. customer service number in your country click here to find.
Gerrit Klaerner is the CEO of Tricida, Inc..
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.